AXL is a candidate receptor for SARS-CoV-2 that promotes infection of pulmonary and bronchial epithelial cells.
AXL is a candidate receptor for SARS-CoV-2 that promotes infection of pulmonary and bronchial epithelial cells.
复制标题
AXL 是 SARS-CoV-2 的候选受体,可促进肺和支气管上皮细胞的感染
DOI:
10.1038/s41422-020-00460-y
复制
发表时间:
2021-03
期刊:
影响因子:
44.1
通讯作者:
Li X
中科院分区:
文献类型:
--
作者:
Wang S;Qiu Z;Hou Y;Deng X;Xu W;Zheng T;Wu P;Xie S;Bian W;Zhang C;Sun Z;Liu K;Shan C;Lin A;Jiang S;Xie Y;Zhou Q;Lu L;Huang J;Li X
The current coronavirus disease 2019 (COVID-19) pandemic presents a global public health challenge. The viral pathogen responsible, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), binds to the host receptor ACE2 through its spike (S) glycoprotein, which mediates membrane fusion and viral entry. Although the role of ACE2 as a receptor for SARS-CoV-2 is clear, studies have shown that ACE2 expression is extremely low in various human tissues, especially in the respiratory tract. Thus, other host receptors and/or co-receptors that promote the entry of SARS-CoV-2 into cells of the respiratory system may exist. In this study, we found that the tyrosine-protein kinase receptor UFO (AXL) specifically interacts with the N-terminal domain of SARS-CoV-2 S. Using both a SARS-CoV-2 virus pseudotype and authentic SARS-CoV-2, we found that overexpression of AXL in HEK293T cells promotes SARS-CoV-2 entry as efficiently as overexpression of ACE2, while knocking out AXL significantly reduces SARS-CoV-2 infection in H1299 pulmonary cells and in human primary lung epithelial cells. Soluble human recombinant AXL blocks SARS-CoV-2 infection in cells expressing high levels of AXL. The AXL expression level is well correlated with SARS-CoV-2 S level in bronchoalveolar lavage fluid cells from COVID-19 patients. Taken together, our findings suggest that AXL is a novel candidate receptor for SARS-CoV-2 which may play an important role in promoting viral infection of the human respiratory system and indicate that it is a potential target for future clinical intervention strategies.
登录
查看更多内容
DOI:
10.1126/science.abd3072
发表时间:
2020-11-13
期刊:
Science (New York, N.Y.)
影响因子:
--
作者:
Daly JL;Simonetti B;Klein K;Chen KE;Williamson MK;Antón-Plágaro C;Shoemark DK;Simón-Gracia L;Bauer M;Hollandi R;Greber UF;Horvath P;Sessions RB;Helenius A;Hiscox JA;Teesalu T;Matthews DA;Davidson AD;Collins BM;Cullen PJ;Yamauchi Y
通讯作者:
Yamauchi Y
影响因子:
64.8
作者:
Li W;Moore MJ;Vasilieva N;Sui J;Wong SK;Berne MA;Somasundaran M;Sullivan JL;Luzuriaga K;Greenough TC;Choe H;Farzan M
通讯作者:
Farzan M
影响因子:
64.5
作者:
Daniloski Z;Jordan TX;Wessels HH;Hoagland DA;Kasela S;Legut M;Maniatis S;Mimitou EP;Lu L;Geller E;Danziger O;Rosenberg BR;Phatnani H;Smibert P;Lappalainen T;tenOever BR;Sanjana NE
通讯作者:
Sanjana NE
影响因子:
56.9
作者:
Lamers, Mart M.;Beumer, Joep;Clevers, Hans
通讯作者:
Clevers, Hans
影响因子:
6.7
作者:
Jemielity S;Wang JJ;Chan YK;Ahmed AA;Li W;Monahan S;Bu X;Farzan M;Freeman GJ;Umetsu DT;Dekruyff RH;Choe H
通讯作者:
Choe H